For localized information and support, would you like to switch to your country-specific website for {0}?
Overview
Ahead of care
Join Roche at IFCC WorldLab 2026, our premier scientific meeting in the field of laboratory medicine, as we explore how, together, we can stay ahead of care.
Join us on a captivating journey as we explore our commitment to advancing patient care through sustainable, innovative, and integrated solutions. Achieving true integration is about going beyond connectivity and individual technologies. In the Roche lab, every component is designed to work together as one, expanding the efficiency, scope, and quality of diagnostics capabilities.
Visit us at the Roche booth to meet the team and see how we can help you to address the challenges your lab is facing.
Let’s explore together how we can help you build an intelligent and integrated lab for a sustainable future—and how, together, we can stay ahead of care.
Highlights of the booth
This event is a premier opportunity to explore the forefront of medical innovation. The immersive experience at our booth will inspire you to learn about:
- cobas® smart e analyzer—Discover the latest offering in Roche’s industry-leading cobas immunoassay systems portfolio. This compact analyzer brings simplicity and efficiency to the laboratory. Designed with a broad assay menu, high reagent capacity and ease of use, it offers a flexible solution for laboratories across different settings.
- cobas® Mass Spec solution—Enter a new dimension of mass spectrometry with us and witness the innovations bringing automation and integration to the superior detection technology. Come and discuss the clinical applications which will benefit from mass spectrometry testing and how the workflow in your laboratory can be improved.
- Biomarkers for neurological disorders—Seamless integration into your lab with known workflows, performance and Elecsys® quality. Neurological disorders are one of the greatest challenges of our century, threatening the very essence of who we are. With a continuous global rise, prevalence is expected to double by 2050.1 Historically, neurological tests have been sporadic and often accessible via specialized labs only. Bringing advanced neuro biomarkers into your routine lab is a game-changer. Fully integrated systems with known workflows and consistent, robust and reliable performance deliver critical neurological answers to clinicians fast. With symptoms often complex and overlapping, accessible and scalable solutions with reproducible and high-quality biomarkers provide the clarity and precision needed for confident, informed decision-making supporting diagnosis, disease monitoring, and therapy evaluation.2,3
- Lipoprotein(a)—Uncover the hidden cardiovascular threat impacting 1 in 5 people who live with elevated Lipoprotein(a), a silent risk factor that largely escapes detection through standard lipid panels. Drop by our booth to explore how once-in-a-lifetime Lp(a) testing and precise lab quantification in nmol/L can close the clinical implementation gap and refine lifelong patient care.
- Infectious diseases—We aim to stand by your side as your partner of choice in Infectious Diseases through continuous investment in scientific innovation for an ever growing menu of validated, fast, and reliable assays. Roche applies a patient-centric approach, focusing on maximising medical value and improving patient outcomes. Our solutions for infectious diseases address high-impact global health challenges, including viral hepatitis, sexually transmitted and congenital infections, vector-borne diseases, and respiratory tract infections. Supporting these efforts, our recently launched Elecsys IGRA TB immunoassay comes to the market as an aid in diagnosing tuberculosis (TB) infection, supporting the global TB elimination goals.
Register now for more information
Register now to stay informed on Roche’s latest activities at the IFCC Congress 2026. Gain exclusive access to insights from our sponsored symposia, in-booth talks and the interactive booth.
References
- World Federation of Neurology. Number of people living with brain disease expected to double by 2050 [Internet; cited 2026 Sep 11]. Available from: https://wfneurology.org/activities/news-events/archived-news/2023-10-16-wcn.
- Fornari A, et al. Inequities in neurological care: Access to services, care gaps, and other barriers—A systematic review. Neurology. 2022;98:123–31.
- Zaman MS, et al. Barriers to accessing healthcare services for people with Parkinson’s disease: A scoping review. Parkinsons Dis. 2023;2023:1–10.